Skip to main content

Table 2 Changes after one year of ILI or SC in patients with T1D and obesity

From: Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study

 

ILI

(n = 77)

SC

(n = 77)

p value

Weight (kg)

-5.6 ± 2.7*

1.6 ± 2.8

 < 0.001

BMI (kg/m2)

-1.8 ± 0.9*

0.6 ± 0.8

 < 0.01

ALT (U/L)

-4.0 ± 2.5

1.9 ± 1.3

 < 0.05

AST (U/L)

-0.6 ± 1.1

0.2 ± 1.6

NS

HbA1c (%)

-0.33 ± 0.15*

-0.07 ± 0.16

NS

Total daily insulin dose (units/d)

-6.1 ± 4.2

1.3 ± 4.3

 < 0.01

Weight-adjusted insulin dose (units/kg/day)

-0.014 ± 0.020

0.004 ± 0.013

NS

Systolic blood pressure (mmHg)

-3.6 ± 2.1

0.4 ± 2.5

NS

Diastolic blood pressure (mmHg)

-1.9 ± 1.3

-0.1 ± 1.4

NS

Total cholesterol (mg/dL)

0.1 ± 6.3

0.9 ± 5.2

NS

LDL-cholesterol (mg/dL)

-4.7 ± 5.4

0.2 ± 3.4

NS

HDL-cholesterol (mg/dL)

1.1 ± 2.9

-0.9 ± 1.0

NS

Triglycerides (mg/dL)

-7.7 ± 13

-0.4 ± 9.0

NS

HSI

-2.7 ± 1.1*

0.6 ± 0.9

 < 0.001

  1. Date are mean ± SEM
  2. ILI Intensive lifestyle intervention, SC Standard diabetes care, HSI Hepatic steatosis index, ALT Alanine aminotransferase, AST Aspartate aminotransferase
  3. *p < 0.05 compared to baseline